KATIE HOLLINGSWORTH: Open Payments
NPI 1053016188 · JEFFERSON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 23 payments from 13 companies in 2025. Trend: 2023 $1,097 · 2024 $2,201 · 2025 $1,345
Food & beverage: $1,051Education: $295
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $221 |
| Kite Pharma, Inc. | 2 | $217 |
| GENZYME CORPORATION | 4 | $192 |
| Pharmacosmos Therapeutics Inc. | 1 | $140 |
| Incyte Corporation | 3 | $136 |
| AstraZeneca Pharmaceuticals LP | 2 | $112 |
| Illumina, Inc. | 2 | $105 |
| SANOFI-AVENTIS U.S. LLC | 1 | $83 |
| Celgene Corporation | 1 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: Yescarta, SARCLISA, MONOFERRIC, Niktimvo, CABLIVI, RYBREVANT, Oncology Testing, DARZALEX.
Industry payments across LA — which companies pay providers there.
